News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
Articles A history of Shire The history of one of the world's biggest speciality and rare disease pharmaceutical companies
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
